In an exciting development for the biotechnology sector, Orna Therapeutics has successfully raised $65 million in a recent funding round aimed at bolstering its innovative genetic medicine platforms. As a clinical-stage biotechnology company, Interius is focused on engineering targeted and programmable vectors that allow for precision delivery of genetic therapies. This transformative approach holds immense potential for treating a wide array of diseases that have traditionally posed significant treatment challenges. The newly acquired funds will be pivotal in advancing Interius' research and development programs, enabling the company to accelerate its clinical trials and bring new, effective solutions to market faster. This infusion of capital will also support the enhancement of their proprietary platform, which seeks to optimize vector designs for improved efficacy and reduced side effects. The success of this funding round not only underscores the growing confidence investors have in the potential of genetically-targeted therapies but also highlights Interius' commitment to addressing unmet medical needs through groundbreaking science. With a talented team and innovative infrastructure in place, Interius is poised to make significant strides in the precision medicine landscape, leading the charge in the fight against challenging and complex diseases. The future looks promising as the company gears up for the next stage of its ambitious journey, aiming to change lives through the power of genetic medicine.
Orna Therapeutics Secures $65 Million in Funding to Advance Precision Genetic Medicine Technology
Recently funded 路 $65.0MBiotechnology
Get the full Orna Therapeutics company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Laihua Online
Wuhan Laihua Information and Technology is an Internet leading source of information on educational opportunities for students to study in other countries especially in China. Either prospect is planning to come to China or is already in China for education (self-support or scholarship based) he will probably need one of the ranges of services we provide from Education, Translation, Notarization of legal documents to Internships & Jobs or Medical Tourism etc. It is a comprehensive directory of study abroad programs, including summer study abroad, service learning, intensive language programs and more. Wuhan Laihua Information and Technology first set out to fill the information gap between students with a desire to travel abroad to study and companies offering international programs.
$68.0M Series d
today
NEW ID
NEW ID is the latest subsidiary company of NEW, which has started up since August 2019 for a new digital contents/platform business domain. We are responsible for expanding the contents produced and acquired by NEW into various markets and creating our digital capabilities through partnering with a-lister digital content creators and providers in Korea.
